genome interpretation Nostos Genomics Aims to Ease Variant Interpretation Bottlenecks With AI Premium The German bioinformatics startup recently partnered with Genomics England and Genomenon as it seeks to accelerate and bring transparency to genetic testing processes. Euformatics Expands Latin American Presence With A&C Group Distribution Deal The deal with A&C Group gives Euformatics a foothold in Bolivia, Peru, and Paraguay, building on an earlier partnership in Brazil. Euformatics Signs Distribution Deal With Saudi Arabia's Al-Jeel Riyadh-based Al-Jeel Medical and Trading Co. is augmenting its NGS partnership with Illumina by adding Euformatics analytics software to its portfolio. Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions. Congenica Strikes Asian Distribution Deal With Camtech Diagnostics Camtech will market and sell Congenica's core clinical decision support platform in Singapore, Malaysia, Japan, and South Korea. Apr 12, 2021 Genomenon, Limbus Medical to Integrate Technologies for Clinical Variant Interpretation Apr 6, 2021 Euformatics Eyes Global Expansion in NGS Informatics Premium Mar 26, 2021 Rare Disease Screening Firm 3billion Closes $13M Series C Financing Mar 18, 2021 Euformatics Partners With Síntese Biotecnologia to Enter Latin American Market Feb 23, 2021 BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research Feb 19, 2021 Qiagen Launches 'Digital Partner' Program to Expand Bioinformatics Reach Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Dec 16, 2020 Illumina, Emedgene Partner on Automated Genomic Data Interpretation Nov 13, 2020 With $50M in New Funding, Congenica Works on Platform Upgrades for Clinical Applications Premium Oct 27, 2020 OmniTier Introduces Appliance for Tertiary Next-Generation Sequencing Analysis Premium Oct 14, 2020 PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis Oct 12, 2020 Geneyx Genomex Acquires NGS Sequencing Analysis Firm Toldot Genetics May 7, 2020 Informatics Startup Breakthrough Genomics Developing Coronavirus Susceptibility Assessment Premium May 5, 2020 PierianDx, University Hospital of Augsburg Tailoring NGS Workflow to European Market Mar 13, 2020 Tempus Closes $100M Series G Round Feb 27, 2020 Sophia Genetics to Provide Access to Genomic Analysis Platform to MGI Customers Feb 6, 2020 Dante Labs Taps BC Platforms for Informatics Support as NGS Testing Ramps Up Premium Dec 20, 2019 Euformatics Picks Alliance Global as Middle Eastern Distributor Nov 25, 2019 Primary Care Professionals May Be Able to Step in to Interpret Genetic Testing Results Sep 18, 2019 GenomSys Raises CHF 9.3M in Series A Round Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.